The University of Maine

DigitalCommons@UMaine
University of Maine Communications

UMaine COVID-19 Community Archive

Spring 2020

COVID-19 Glossary of Terms
University of Maine

Follow this and additional works at: https://digitalcommons.library.umaine.edu/c19_comm
Part of the Higher Education Commons, History Commons, and the Medicine and Health Sciences
Commons
This Report is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for
inclusion in University of Maine Communications by an authorized administrator of DigitalCommons@UMaine. For
more information, please contact um.library.technical.services@maine.edu.

1 8 6 5 THE UNIVERSITY OF

rrn MAINE
~

COVID-19 Science and Medicine Updates
Compiled by University of Maine faculty and students

GLOSSARY OF CLOSELY RELATED TERMS - v1
Pandemic, Epidemic, Outbreak, Endemic - Endemic is the baseline level of
a disease in a community. Epidemic refers to a sudden increase in the number of
cases of a disease in a given population. Outbreak is similar to Epidemic, but refers to
a discrete geographic area. Pandemic is an epidemic that has spread over many
countries and continents.

Quarantine, Self-Isolation, Social/Physical Distancing - Quarantine refers
to removing oneself from interaction with other people when they have been exposed to
the virus or are at risk of coming down with the virus; often quarantine could be imposed
by state or federal law. Seit-isolation is when you have suspected or confirmed
infection, and isolate yourself at home or at a hospital, with caregivers using appropriate
protective equipment. SociaVphysical distancing refers to canceling group gatherings
and limiting person-to-person contact by increasing physical distance by 6+ feet; this
includes behaviors like school closures, working from home, canceling events, and
visiting with friends and relatives digitally and not in person.

Respirator, Ventilator, CPAP, ECMO -A respirator is a facemask with filters
that can remove particles of a certain size. A ventilator assists the lungs with moving
oxygen into the body. CPAP, or continuous positive air pressure, is a mask or
nosepiece that delivers continuous air pressure, often used for sleep apnea. ECMO, or
extracorporeal membrane oxygenation provides oxygenation to a patient's blood outside
the body, in the case of lung and heart problems.

Incubation Period, lnfectivity, Mortality Rate, Reproductive RateIncubation Period is the period between exposure and the onset of initial symptoms.
COVID-19 has a very long incubation period of 2-14 days, during which time people can
be contagious but not have symptoms. The median incubation period is just over 5
days, with 97.5% of people developing symptoms within 11.5 days of infection.
lnfectivity is the ability of a pathogen to infect cells, based on strategies to overcome

detection or reconnaissance by the host cells. The mortality rate, or death rate, for
COVID-19 is estimated at 10x that of influenza, with an average of 1% of the population.
The reproductive rate, or Ro (R naught), is an indication of the transmissibility of a
virus is the number of new cases of the disease an infected person will cause while they
are infectious. This rate for COVID-19 is estimated at 2.2-2.7, while for seasonal
influenza it is -1.5 and for measles it is 12-18.

Virus, Novel Human Virus - a Virus is an infectious agent smaller than bacteria,
that requires a host cell to replicate. A virus consists of a small RNA or DNA genome
surrounded by a protein coat, and some viruses, like SARS-CoV-2 are further
surrounded in a lipid envelope. Viruses can cause a variety of diseases in plants,
animals, and humans. SARS-CoV-2, or COVID-19, is a novel human coronavirus
(like MERS or previous SARS) that began as an outbreak in China in Dec 2019.
Human-to-human transmission first occurred during this time, having jumped as a
zoonotic transmission from animals to humans. Because COVID-19 is a novel human
virus, there are no humans with immunity (from previous exposure or vaccines).

Viral Load, Viral Shedding, Disease Vector, Viral Host, Immunity Viral load is the amount of virus being carried by an infected individual, and being shed
into their environment. This is usually measured by quantitative PCR. Viral shedding
is the process, or period of time, when infected individuals release viral particles that are
produced during viral reproduction in the host individual, and therefore the infected
people are contagious during this period. Viral shedding can occur in asymptomatic
people. A disease vector is an organism that carries pathogens from person to person
or place to place, in the case of some viruses this could be mosquitos or ticks. A viral
host is the organism and its cells that allow a virus to reproduce; viruses cannot
reproduce outside of a host and during infection they insert their genetic material (DNA
or RNA) into the host cells and take over the host cell's functions. Immunity is
achieved through presence of antibodies to a microbe in a person's system. Active
immunity is achieved through antibody production when a person is exposed to an
antigen (foreign substance), or through vaccination. Passive immunity is the transfer of
antibodies, such as maternal transfer to newborns.

Antibodies, Antibiotics, Anti-Viral, Vaccine, Viral Receptor - Antibodies
are produced by the body to neutralize or destroy toxins or disease-carrying organisms,
including viruses. Antibiotics can not kill viruses, and instead are natural or synthetic
compounds that can slow the growth of, or kill, bacteria. Antiviral medications are
used to treat viral, not bacterial, infections, often by reducing viral reproduction.
Vaccines provide active immunity to a virus, by delivering the antigen (or the part of a
microorganism recognized by your immune system, to encourage B lymphocytes to
produce antibodies specific to that virus). These are either dead/inactivated viruses
delivered with an adjuvant, that boosts the body's response to the antigen, or a live
attenuated virus that has been modified to not cause disease and contains naturallyoccurring adjuvants. Vaccines produce an immune response that leads to immunity to a
disease, without causing the disease itself. Long-term protection requires maintained

levels of antibodies in a person's body, capable of fighting off exposure to that virus. A
viral receptor is a component of a person/host's cells that is recognized by the virus
and exploited to gain entry to the host cells, causing an infection. The known receptor
for COVID-19 is called ACE-2 and is expressed in the oral mucsoa, vascular endothelial
cells, lung, kidney, GI tract, cardiac tissue, and other tissues meaning those cell types
are susceptible to COVID-19 infection.

Viral vs Bacterial Pneumonia - Pneumonia is an infection in one or both lungs,
caused by bacteria, viruses, or fungi. With this infection, the airways swell and become
inflamed, and the air sacks in the lungs become filled with fluid. Influenza (Flu) and
SARS-CoV-2 (COVID-19) are examples of viruses that lead to viral pneumonia.

Clean, Sanitize, Disinfect - Cleaning, using a detergent like soap, removes dirt
and impurities, and can physically remove germs. Soap destroys the lipid envelope of
SARS-CoV-2 so is an effective method to inactivate the virus. Sanitizing reduces the
number of germs (bacteria, viruses) on surfaces and objects, while disinfection kills
germs on surfaces using specific chemicals like bleach or alcohol.

Droplets, Aerosol, Airborne - Droplets, or water droplets in the air that contain
inclusions such as physiological materials and viruses, are often greater than 5 microns
and are produced by coughing and sneezing. Since they are heavier, they fall to the
ground more quickly and typically travel only 3-6 feet. Aerosols are smaller droplets
that can travel further and stay in the air for longer. Airborne diseases are able to stay
suspended in the air for longer periods and are therefore more transmissible, such as
measles.

Epidemiologist, Infectious Disease Expert, Virologist - Epidemiologists
search for the cause of disease, identify people who are at risk, determine how to
control or stop the spread or prevent it from happening again. An infectious disease
expert is expert in the diagnosis and treatment of diseases caused by microorganisms,
including bacteria, viruses, fungi and parasites; infectious diseases are the second
leading cause of death worldwide. A virologist conducts research on viruses and how
they function.

CDC, WHO - CDC is the centers for disease control and prevention, headquartered in
Atlanta, GA, works to protect the United States from health, safety, and security threats.
CDC branches are also found in each state, such as the Maine CDC. WHO is the
World Health Organization, headquartered in Geneva, Switzerland, works worldwide to
promote health, keep the world safe, and serve the vulnerable.

Other Commonly Used Terms:
Fomites - porous and non-porous surfaces that can become contaminated with
pathogenic microorganisms
Exponential Growth - increase in incidence with a rapid doubling time; COVID-19
has a doubling time of about 2.5 days
Flattening the Curve -When a large number of people become sick over a short
period of time, hospitals and healthcare resources become overwhelmed and there can
be a shortage of supplies, medical equipment, and healthcare personnel. If the same
number of patients become sick over a longer period of time, this removes the burden
on the hospitals and healthcare system.
Self-Monitoring - checking oneself for symptoms (for COVID-19, this includes fever,
dry cough, shortness of breath or difficulty breathing)
Herd Immunity-when a community is protected from a virus, by a combination of
vaccination and immunity (antibody production by the immune system) in people who
previously had the disease, for a large portion of the population
Zoonotic Disease - diseases spread between animals and people. COVID-19 is a
disease that originated in animals and is newly infectious in humans.

Useful sources:
https://www .cdc.gov/csels/dsepd/ss1978/lesson1 /section11.html
https ://my.clevelandclinic.org/health/d iseases/4471-pneumonia
https://www .ncbi.nlm.nih.gov/books/NBK143281 /
https ://www .cdc.govlvaccines/vac-gen/imm unity-types. htm
https ://www.nature.com/articles/s41591-020-0796-5
https ://www .genome.gov/genetics-glossaryNi rus
https ://www .sciencedaily.com/releases/2020/03/200317175438. htm
https ://labblog. uofm health.org/rou nds/how-scientists-guantify-intensity-of-an-outbreak-like-covid19
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